Press release
The STING pathway targeting technologies market, featuring a healthy pipeline of therapeutics, is anticipated to be worth over USD 2.8 billion by 2030, predicts Roots Analysis
Roots Analysis is pleased to announce the publication of its recent study, titled, “STING Pathway Targeting Therapeutics and Technologies, 2020-2030.”
The report features an extensive study of the current market landscape and future potential of these therapeutics and affiliated technologies, over the next decade. This study focuses specifically on small molecule STING modulators. The report features an in-depth analysis, highlighting the diverse capabilities of stakeholders engaged in this domain. In addition to other elements, the study includes:
A detailed assessment of the current market landscape of therapeutics targeting STING Pathway.
A detailed assessment of the current market landscape of various technology platforms that are being actively used for the development of STING modulators.
Detailed profiles of developers of therapeutics targeting STING pathway (shortlisted on the basis of phase of development of pipeline products).
An in-depth analysis of more than 280 grants that have been awarded to research institutes engaged in STING pathway targeting therapeutics-related projects.
An analysis of the initiatives of big pharma players engaged in this domain.
An analysis of the start-ups / small players (established in the last ten years, less than 50 employees) engaged in the development of STING pathway targeting therapeutics.
A detailed publication analysis of more than 300 peer-reviewed, scientific articles that have been published during the period 2019 - Q1 2020.
An analysis of the partnerships that have been established in this domain, in the recent past.
An analysis of the investments made in this domain.
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
Types of Payment
Upfront Payments
Milestone Payments
Type of STING Modulator
Agonist
Antagonist
Key Therapeutic Area(s)
Oncological Disorders
Inflammatory Disorders
Infectious Diseases
Others
Route of Administration
Intratumoral
Intravenous
Oral
Subcutaneous
Others
Type of Molecule
Non-nucleotide
Cyclic Dinucleotide
Live Biotherapeutics
Oncolytic Peptides
Synthetic Peptides
Others
Key Geographical Regions
North America
Europe
Asia-Pacific
Key companies covered in the report
Aduro Biotech
Bristol Myers Squibb
Eisai
GlaxoSmithKline
ImmuneSensor Therapeutics
Merck
Noxopharm
Spring Bank Pharmaceuticals
Synlogic
For more information please click on the following link:
https://www.rootsanalysis.com/reports/sting-pathway-targeting-therapeutics-and-technologies-market.html
Other Recent Offerings
1. Nuclear Medicine and Radiopharmaceuticals Manufacturing Market, 2020-2030
2. Global Psychedelic Therapeutics Market by Type of Psychedelic Substance (Ketamine, Psilocybin, MDMA and Others), by Origin (Natural and Synthetic), by Type of Therapy (Monotherapy, Combination and Others), by Route of Administration (Oral, Intravenous, Intranasal and Others) and by Key Geographies (North America, Europe and Asia- Pacific and rest of the world): Industry Trends and Global Forecasts, 2020-2030
3. Endocannabinoid System Targeted Therapeutics Market, 2020-2030
Contact:
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com
Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The STING pathway targeting technologies market, featuring a healthy pipeline of therapeutics, is anticipated to be worth over USD 2.8 billion by 2030, predicts Roots Analysis here
News-ID: 2224616 • Views: …
More Releases from Roots Analysis
Pharmaceutical Contract Manufacturing Market CAGR To Reach 4.5% between 2025 and …
According to our latest market report "Pharmaceutical Contract Manufacturing Market by Type of Product Manufactured, Type of API, API Potency, Type of FDF, Dosage Form, Type of Oral Solid, Type of Packaging Offered, Scale of Operation, End User, Geographical Regions and Key Players: Industry Trends and Global Forecasts, till 2035", the pharmaceutical contract manufacturing market is estimated to be USD 100.3 billion in 2025. It is expected to reach USD…
Cell Therapy Manufacturing Market CAGR To Exceed 8.25% by 2035, Due to the Growi …
According to our latest market report "Cell Therapy Manufacturing Market by Type of Cell Therapy, Source of Cells, Scale of Operation, Type of Manufacturer and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035", the global cell therapy manufacturing market size is projected to reach USD 14,017 million by 2035 from USD 6,343 million in 2025, growing at a CAGR of 8.25% in the forecast period 2025-2035.
To request quote…
T-Cell Therapy Market Size to Hit USD 20.9 billion by 2035| Exclusive Report by …
Cancer is one of the leading causes of mortality across the world. As per the International Agency for Research on Cancer (IARC), by 2040, there are likely to be 27.5 million new cases and 16.3 million deaths related to cancer, annually. Although cancer therapeutics continue to be one of the most active areas, in terms of drug development, there is still a significant unmet need in this domain. In fact,…
Cancer Biologics Market: Unmet Need and Treatment Guidelines
Owing to the increasing mortality rates and growing need for novel modalities to treat oncological disorders, several researchers and industry stakeholders have shifted their focus on the development of safe and effective biologic therapies. Cancer biologics are the class of therapeutic agents, which primarily modulate immune responses or directly inhibits oncogenic pathways in malignancies. These therapies, such as monoclonal antibodies, specifically target tumor-activating genes, facilitate antibody-dependent cellular cytotoxicity and complement…
More Releases for STING
No Sting Medical Adhesive Remover Market Expected to Reach $1.2 Billion by 2034
Mumbai, India - December 15, 2025 - Exactitude Consultancy, a leading global market research and consulting firm, has released its comprehensive No Sting Medical Adhesive Remover Market report, forecasting strong growth over the next decade. The global market, valued at approximately USD 600 million in 2024, is expected to expand at a compound annual growth rate (CAGR) of 7.5 %, reaching USD 1.2 billion by 2034.
Download Full PDF Sample Copy…
CGAS-STING Pathway Market Pioneering Advances in Immunotherapy and Cancer Treatm …
The global CGAS-STING pathway market is set to experience rapid growth, driven by breakthroughs in immunotherapy and the growing adoption of STING agonists in cancer treatment.
Introduction:
The global CGAS-STING pathway market is witnessing significant growth, driven by increasing interest in the STING (Stimulator of Interferon Genes) pathway as a target for cancer immunotherapy. The CGAS-STING pathway plays a crucial role in the body's immune response to infections and tumors. Research into…
Talaria Expands Its Groundbreaking Sting Lineup with the New Talaria Sting MX5
Talaria [https://talariaebikes.company.site/], a global leader in lightweight electric off-road motorcycles, proudly announces the launch of its latest innovation, the Talaria Sting MX5, a high-performance electric dirt bike designed to push the boundaries of agility, durability, and rider experience. Building on the success of the original Sting series, the MX5 joins an expanding lineup of models including the Sting R, Sting L1E, and Sting MX3, offering riders around the world even…
Sting! XXIV: Rites of Spring…. An Evening of Art, Music and Performance at Bos …
On Wednesday, March 29th, 2017 from 6:30PM - 8:30PM, The Beehive's co-owner and resident curator Jennifer Epstein and guest curator Ian Marcus Corbin of Matter & Light Fine Art are pleased to present the 24th installment in The Beehive's continuing art series entitled “Rites of Spring: Rebirth in Color and Form.” This multi-artist exhibition features vibrantly colored, sensuous abstract paintings that recall the vital, explosive energies of spring.
Ian Marcus…
Sting! XXIII: Oh. Sheet!... An Evening of Art, Music and Performance at Boston …
WHAT: On Tuesday, November 29th, 2016 from 6:30PM - 8:30PM, The Beehive's co-owner and resident curator Jennifer Epstein and guest curator Olivia Ives-Flores of Oh Olive Creative are pleased to present the 23rd installment in The Beehive's continuing art series entitled Oh. Sheet, a works on paper group show. The exhibition features a diverse selection of Boston, New York,…
Mysterious chillout music: Knead & Sting - Shattered
Knead And Sting is the name of the duo Michael Knead and Alexander Sting. Both artists have become known with releases in the field of Techno and Progressive House. Who thinks, however, that they are producing Tech-House together is wrong: the Knead And Sting project stands for the collaboration of two musical free thinkers beyond all genre limitations. Their single Shattered is the second chapter of the new german Electronica…
